Takara, T.; Takara, R.; Kobayashi, A.; Shirakata, H.; Ambai, S.; Shinohara, Y.; Uto, Y.
Serum-Derived Macrophage-Activating Factor Exhibits Anti-Tumor Activity via M2-to-M1 Macrophage Reprogramming. Int. J. Transl. Med. 2024, 4, 439-449.
https://doi.org/10.3390/ijtm4030029
AMA Style
Takara T, Takara R, Kobayashi A, Shirakata H, Ambai S, Shinohara Y, Uto Y.
Serum-Derived Macrophage-Activating Factor Exhibits Anti-Tumor Activity via M2-to-M1 Macrophage Reprogramming. International Journal of Translational Medicine. 2024; 4(3):439-449.
https://doi.org/10.3390/ijtm4030029
Chicago/Turabian Style
Takara, Tsuyoshi, Rei Takara, Aya Kobayashi, Hina Shirakata, Shinobu Ambai, Yusei Shinohara, and Yoshihiro Uto.
2024. "Serum-Derived Macrophage-Activating Factor Exhibits Anti-Tumor Activity via M2-to-M1 Macrophage Reprogramming" International Journal of Translational Medicine 4, no. 3: 439-449.
https://doi.org/10.3390/ijtm4030029
APA Style
Takara, T., Takara, R., Kobayashi, A., Shirakata, H., Ambai, S., Shinohara, Y., & Uto, Y.
(2024). Serum-Derived Macrophage-Activating Factor Exhibits Anti-Tumor Activity via M2-to-M1 Macrophage Reprogramming. International Journal of Translational Medicine, 4(3), 439-449.
https://doi.org/10.3390/ijtm4030029